| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 45 |
| 1 | CLOZAPINE | 24 |
| 2 | OLANZAPINE | 23 |
| 3 | ARIPIPRAZOLE | 22 |
| 4 | LAMOTRIGINE | 22 |
| 5 | VARENICLINE TARTRATE | 22 |
| 6 | LORAZEPAM | 21 |
| 7 | CLONAZEPAM | 20 |
| 8 | PREGABALIN | 18 |
| 9 | FLUOXETINE HYDROCHLORIDE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOMAPACITAN-BECO | 1 | 0.0055 |
| 1 | FLUPHENAZINE DECANOATE | 2 | 0.0046 |
| 2 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 3 | LEVOKETOCONAZOLE | 1 | 0.0013 |
| 4 | AMISULPRIDE | 8 | 0.0013 |
| 5 | ZIPRASIDONE | 4 | 0.0011 |
| 6 | INSULIN LISPRO-AABC | 2 | 0.0009 |
| 7 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 8 | CHLORZOXAZONE | 1 | 0.0008 |
| 9 | ILOPERIDONE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 74 |
| 1 | Benzodiazepine [EPC] | 57 |
| 2 | Mood Stabilizer [EPC] | 31 |
| 3 | Anti-epileptic Agent [EPC] | 28 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 5 | Proton Pump Inhibitor [EPC] | 13 |
| 6 | Macrolide Antimicrobial [EPC] | 12 |
| 7 | Opioid Agonist [EPC] | 10 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 10 |
| 9 | Vitamin C [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 8 | 0.0010 |
| 2 | Amyloid Beta-directed Antibody [EPC] | 2 | 0.0005 |
| 3 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 4 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 3 | 0.0004 |
| 5 | Cholinesterase Inhibitor [EPC] | 6 | 0.0003 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 7 | Typical Antipsychotic [EPC] | 6 | 0.0002 |
| 8 | Macrolide Antimicrobial [EPC] | 12 | 0.0002 |
| 9 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |